← Leaderboards
Kenneth W Witwer
Johns Hopkins University
$12,072,332
Attributed
$15,918,892
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2013–23$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$15,918,892 · 10
By mechanism
R01$9,985,646 · 3
R33$2,171,020 · 1
UH3$1,098,173 · 1
UG3$940,560 · 1
R21$914,409 · 2
R56$796,284 · 1
Top collaborators
- Vasiliki Machairaki7 shared
- Bharat Ramratnam5 shared
- Linzhao Cheng1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Jonathan R Terman$9,832,543
- Vasiliki Machairaki$4,436,271
- Allen C Myers$3,195,723
- Jacques Ravel$18,661,935
- Rolf U. Halden$3,597,695
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingCellsExtracellular VesiclesPlasmaBiologicalBiological MarkersTissuesParticlePathogenesisValidationCentral Nervous System DiseasesNeuronsAstrocytesInnovationCell TypeDiagnosisBaseCd4 Positive T LymphocytesTechnologyBrainAttentionAntiretroviral TherapyHiv-1Acquired Immunodeficiency Syndrome
Grant awards (30)
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV$770,678
R01 · FY2023 · AI · contact PI
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV$786,419
R01 · FY2022 · AI · contact PI
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles$688,315
R33 · FY2022 · MH · contact PI
Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use$644,257
R01 · FY2022 · DA · contact PI
Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein Aggregates$549,041
UH3 · FY2022 · CA · contact PI
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV$796,244
R01 · FY2021 · AI · contact PI
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles$724,315
R33 · FY2021 · MH · contact PI
Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use$639,099
R01 · FY2021 · DA · contact PI
Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein Aggregates$549,132
UH3 · FY2021 · CA · contact PI
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV$805,578
R01 · FY2020 · AI · contact PI
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles$758,390
R33 · FY2020 · MH · contact PI
Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use$657,757
R01 · FY2020 · DA · contact PI
Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein Aggregates$453,514
UG3 · FY2020 · CA · contact PI
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV$830,593
R01 · FY2019 · AI · contact PI
Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use$661,287
R01 · FY2019 · DA · contact PI
Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein Aggregates$487,046
UG3 · FY2019 · CA · contact PI
Extracellular Vesicle-Mediated Immunomodulation in HIV Infection and Nicotine Abuse$457,682
R01 · FY2019 · DA · contact PI
Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use$376,451
R01 · FY2019 · DA · contact PI
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles$245,705
R21 · FY2019 · MH · contact PI
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles$20,564
R21 · FY2019 · MH · contact PI
Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use$691,473
R01 · FY2018 · DA · contact PI
Extracellular Vesicle-Mediated Immunomodulation in HIV Infection and Nicotine Abuse$460,922
R01 · FY2018 · DA · contact PI
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles$204,607
R21 · FY2018 · MH · contact PI
Discovering novel players in mechanisms of extracellular vesicle release, cargo loading, and early pathogenesis of late-onset Alzheimer's Disease$796,284
R56 · FY2017 · AG · contact PI
Extracellular Vesicle-Mediated Immunomodulation in HIV Infection and Nicotine Abuse$448,690
R01 · FY2017 · DA · contact PI
Extracellular Vesicle-Mediated Immunomodulation in HIV Infection and Nicotine Abuse$463,289
R01 · FY2016 · DA · contact PI
Extracellular Vesicle-Mediated Immunomodulation in HIV Infection and Nicotine Abuse$495,227
R01 · FY2015 · DA · contact PI
International Society for Extracellular Vesicles - Education Day & Meeting$12,800
R13 · FY2015 · TR · contact PI
Circulating Cellular and Extracellular Noncoding RNAs in HIV-1 Elite Suppression$240,739
R21 · FY2014 · AI · contact PI
Circulating Cellular and Extracellular Noncoding RNAs in HIV-1 Elite Suppression$202,794
R21 · FY2013 · AI · contact PI